SinoMab Doses First Patient in Clinical Study of Atopic Dermatitis Drug in China
SinoMab Doses First Patient in Clinical Study of Atopic Dermatitis Drug in China
SinoMab在中国对特应性皮炎药物进行了临床研究并给第一位患者注射剂量
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册